Trastuzumab Withdrawn Phase 0 Trials for Advanced Solid Tumors / Documented Her2 Overexpression / Metastatic Brain Tumors / Neurologically Stable Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment0
clinicaltrials.gov IdentifierTitleDrugs
NCT0273579864-Cu Labeled Brain PET/MRI for MM-302 in Advanced HER2+ Cancers With Brain Mets